Patrick Haley
Corporate Officer/Principal chez EXELIXIS, INC.
Fortune : 10 M $ au 31/03/2024
Profil
Patrick J.
Haley's current job is as the Executive Vice President-Commercial at Exelixis, Inc. His former job was as the Group Manager-Product at Genentech, Inc. from 2007 to 2010.
Mr. Haley completed his undergraduate degree at Duke University and holds an MBA from the Stephen M.
Ross School of Business.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
EXELIXIS, INC.
0,14% | 23/02/2024 | 419 053 ( 0,14% ) | 10 M $ | 31/03/2024 |
Postes actifs de Patrick Haley
Sociétés | Poste | Début |
---|---|---|
EXELIXIS, INC. | Corporate Officer/Principal | 01/11/2014 |
Anciens postes connus de Patrick Haley
Sociétés | Poste | Fin |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2010 |
Formation de Patrick Haley
Duke University | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EXELIXIS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |